Literature DB >> 16629702

Immunohistological features of visceral leishmaniasis in BALB/c mice.

J Carrión1, A Nieto, S Iborra, V Iniesta, M Soto, C Folgueira, D R Abanades, J M Requena, C Alonso.   

Abstract

It has been reported that the level of protection provided by vaccines against murine visceral leishmaniasis (VL) is low and that progress in research on VL may be due to the lack of appropriate models to study protective immunity. We have analysed the immunohistological features occurring in BALB/c mice after intravenous administration of 10(3), 10(5) and 10(6) parasites of Leishmania infantum. Our results show that in all cases parasite administration leads to the establishment of infection and to the development of quantifiable immunohistological features which are dependent on the inoculum size. This study demonstrates that differences in the parasite challenge result in changes in the evolution of some of the parameters associated with the degree of the infection in the BALB/c model: level of anti-Leishmania antibodies, up-regulation of spleen arginase activity, balance between IFN-gamma and IL-10, extent of lymphoid follicle depletion in the splenic white pulp and ineffective development of hepatic granulomas. Also, and depending on the initial infectious inoculum, the absence of parasites in the bone marrow and the number of mature and empty type granulomas were parameters associated with protection. We think that in this model a challenge of the order of 10(5) parasites should prove useful for vaccine studies against VL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629702     DOI: 10.1111/j.1365-3024.2006.00817.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  41 in total

1.  Achievement amastigotes of Leishmania infantum and investigation of pathological changes in the tissues of infected golden hamsters.

Authors:  Sajad Rashidi; Kurosh Kalantar; Gholamreza Hatam
Journal:  J Parasit Dis       Date:  2018-03-05

2.  MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.

Authors:  Sanjay Varikuti; Gayathri Natarajan; Greta Volpedo; Bhawana Singh; Omar Hamza; Gretchen V Messick; Mireia Guerau-de-Arellano; Tracey L Papenfuss; Steve Oghumu; Abhay R Satoskar
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.

Authors:  Levi Eduardo Soares Reis; Rory Cristiane Fortes de Brito; Jamille Mirelle de Oliveira Cardoso; Fernando Augusto Siqueira Mathias; Rodrigo Dian Oliveira Aguiar Soares; Claudia Martins Carneiro; Paula Melo de Abreu Vieira; Guilherme Santos Ramos; Frédéric Jean Georges Frézard; Bruno Mendes Roatt; Alexandre Barbosa Reis
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites.

Authors:  Dulcilene M Oliveira; Mariana Amália F Costa; Miguel A Chavez-Fumagalli; Diogo G Valadares; Mariana C Duarte; Lourena E Costa; Vivian T Martins; Rosângela F Gomes; Maria N Melo; Manuel Soto; Carlos Alberto P Tavares; Eduardo Antonio F Coelho
Journal:  Parasitol Res       Date:  2011-09-14       Impact factor: 2.289

5.  T-cell populations and cytokine expression are impaired in thymus and spleen of protein malnourished BALB/c mice infected with Leishmania infantum.

Authors:  Sergio Cuervo-Escobar; Monica Losada-Barragán; Adriana Umaña-Pérez; Renato Porrozzi; Leonardo Saboia-Vahia; Luisa H M Miranda; Fernanda N Morgado; Rodrigo C Menezes; Myriam Sánchez-Gómez; Patricia Cuervo
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

6.  Functionalized 1,2,3-triazolium salts as potential agents against visceral leishmaniasis.

Authors:  Ayla das Chagas Almeida; Raíssa Soares Meinel; Yasmim Lopes Leal; Thiago P Silva; Nícolas Glanzmann; Débora Vasconcelos Costa Mendonça; Luísa Perin; Edézio Ferreira Cunha-Júnior; Eduardo A F Coelho; Rossana C N Melo; Adilson David da Silva; Elaine Soares Coimbra
Journal:  Parasitol Res       Date:  2022-02-16       Impact factor: 2.289

7.  An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.

Authors:  Letícia Martins Dos Reis Lage; José Mário Barichello; Daniela Pagliara Lage; Débora Vasconcelos Costa Mendonça; Ana Maria Ravena Severino Carvalho; Marcella Rezende Rodrigues; Daniel Menezes-Souza; Bruno Mendes Roatt; Ricardo José Alves; Carlos Alberto Pereira Tavares; Eduardo Antonio Ferraz Coelho; Mariana Costa Duarte
Journal:  Parasitol Res       Date:  2016-07-01       Impact factor: 2.289

8.  Does Leishmaniasis disease alter the parenchyma and protein expression in salivary glands?

Authors:  Aírton M C Júnior; Fernando A de Amorim Carvalho; Weslany de Oliveira Dantas; Luana C L Gomes; Andrezza B S da Silva; Maria M A de Sousa Cavalcante; Ingrid M de Oliveira; Marina de Deus Moura de Lima; Márcia Dos Santos Rizzo; Carla Maria de Carvalho Leite; Selma Maria Dos Santos Moura; Lúcia de Fátima Almeida de Deus Moura; Benedito B da Silva
Journal:  Exp Biol Med (Maywood)       Date:  2015-11-13

9.  Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis.

Authors:  Sukhbir Kaur; Tejinder Kaur; Nishma Garg; Sudeshna Mukherjee; Puneet Raina; Voleentina Athokpam
Journal:  Parasitol Res       Date:  2008-08-27       Impact factor: 2.289

10.  Immunobiology of visceral leishmaniasis.

Authors:  Rajiv Kumar; Susanne Nylén
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.